The Progress of Next Generation Sequencing in the Assessment of Myeloid Malignancies
Journal Title: Balkan Medical Journal - Year 2019, Vol 36, Issue 2
Abstract
The introduction and advances on next-generation sequencing have led to novel ways to integrate simultaneous assessment of multiple target genes in routine laboratory analysis. Assessment of myeloid neoplasms with targeted next-generation sequencing panels shows evidence to improve diagnosis, assist therapeutic decisions, provide better information about prognosis, and better detection of minimal residual disease. Herein, we provide information for application and utilization of next-generation sequencing studies with a focus on the most important mutations in acute myeloid leukemia, myelodysplastic syndrome, myeloproliferative neoplasms, and other myelodysplastic/myeloproliferative neoplasms in order to integrate them into the daily clinical practice.
Authors and Affiliations
Fulya Öz Puyan, Serhan Alkan
Keywords
Related Articles
- EP ID EP534019
- DOI 10.4274/balkanmedj.galenos.2018.2018.1195
- Views 59
- Downloads 0
Congenital Superior Sternal Cleft Repair Using Primary Closure
.
General Concepts in Adult Congenital Heart Disease
Congenital heart disease in adults (adult congenital heart disease) is a growing burden for healthcare systems. While infant mortality due to congenital heart disease in the last four decades decreased by almost 3-fold,...
MicroRNA Expression Profile in the Prenatal Amniotic Fluid Samples of Pregnant Women with Down Syndrome
Background: Down syndrome, which is the most common human chromosomal anomaly that can affect people of any race and age, can be diagnosed prenatally in most cases. Prenatal diagnosis via culture method is time-consuming...
Increasing the Impact Factor in the Ethical Way
.
A Short History of Trakya University Faculty of Medicine
.